Learning Center

Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Type
Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Contains 5 Component(s)

    This webinar will feature updated definitions of point of care (POC) manufacturing and feature two leading innovators in POC manufacturing to offer real-world examples of – and insights from – successful POC programs. Real-life experts will speak about their experience of building a point-of-care manufacturing program at a clinical laboratory. They will discuss the challenges, the potential solutions, and the regulatory aspects of in-house manufacturing, and provide perspective from the different vantage points of their respective roles.

    Presented by the ISCT North America Regional Executive Committee and Lab Practices Committee

    March 12, 2024

    Webinar Description:

    This webinar will feature updated definitions of point of care (POC) manufacturing and feature two leading innovators in POC manufacturing to offer real-world examples of – and insights from – successful POC programs. 

    Real-life experts will speak about their experience of building a point-of-care manufacturing program at a clinical laboratory. They will discuss the challenges, the potential solutions, and the regulatory aspects of in-house manufacturing, and provide perspective from the different vantage points of their respective roles.

    Key Learning Objectives:

    • To discuss the regulatory landscape surrounding point-of-care manufacturing of cell and gene therapy products from the FDA perspective.

    • To delineate the process of establishing a point-of-care manufacturing program in an academic institution.

    • To highlight potential challenges and possible solutions from the experts who have built successful programs.

    Ashley Krull, PhD (Moderator)

    Associate Director, W.W. Williams Cellular Therapy Laboratory

    The Ohio State University

    Ashley Krull received her undergraduate degree in Biochemistry from the University of Iowa and her Ph.D. in Neuroscience from the University of Washington. After graduate school, Dr. Krull completed a postdoctoral fellowship in regenerative neurobiology within the Department of Neurology at Mayo Clinic in Rochester, Minnesota. In 2019, Dr. Krull became Mayo Clinic’s second-ever Cellular Therapy Fellow and was granted an extended two-year fellowship, which she completed in 2021. This fellowship program included didactic, experiential, and project-driven training with an emphasis on directorship of a clinical cell therapy laboratory. Subsequently, Dr. Krull held an appointment as Instructor within the Department of Laboratory Medicine and Pathology and served as a senior program coordinator within the Mayo Clinic cellular therapy lab and as a consultant for a joint venture biotechnology company spun out of the lab’s work at Mayo Clinic. In 2022, Dr. Krull moved to The Ohio State University where she currently serves as the Associate Director of Cell Therapy Manufacturing and Engineering. She also holds an appointment of Assistant Professor within the Department of Hematology. Her work focuses on the optimization of manufacturing processes for immune effector cells and the translation of novel cellular therapies into the clinic.

    Elena Maryamchik, MD, MBA (Moderator)

    Director of Cell Therapy Laboratory

    Memorial Sloan Kettering Cancer Center

    After receiving a dual MD/MBA degree from the University of Miami in 2016, Elena completed her residency in Clinical Pathology at the Massachusetts General Hospital, Cell and Gene Therapy Fellowship at the University of Pennsylvania/Children’s Hospital of Philadelphia, and Transfusion Medicine Fellowship at Harvard. She is a Director of Cell Therapy Laboratory at Memorial Sloan Kettering Cancer Center, and an Assistant Attending in Transfusion Medicine. Her interests include Point-of-Care manufacturing of cell therapy products, exploring the role of stem cell graft characterization and post-thaw viability monitoring in guiding clinical decisions and improving patient outcomes, developing training programs to facilitate the entry of qualified technicians into the field of cell therapy, teaching the next generation of cell therapy leaders, and optimizing operations of a clinical laboratory to meet the rising demand. As an early-stage professional, she is a member of ISCT Lab Practices Committee, ISCT Expanded Access Working Group, ASTCT representative to the AABB COI for Cellular Therapies Task Force, and a member of the FACT-JACIE Standards HCT Processing Subcommittee.

    Kimberly Schultz, PhD

    Director of Division 2, Office of Gene Therapy

    US Food and Drug Administration (FDA)

    Kimberly Schultz is Director of Division 2 in the Office of Gene Therapy at FDA’s Office of Therapeutic Products in the Center for Biologics Evaluation.  Kim joined the FDA in 2015 as a Commissioner’s Fellow to conduct a cross-study analysis of CAR T cell CMC data and contributes to FDA review, guidance, and policy.  Prior to joining the FDA, she received her PhD from the University of Wisconsin and conducted postdoctoral studies at Johns Hopkins Bloomberg School of Public Health specializing in virology and immunology.

    Yongping Wang, MD, PhD

    Director, Cell and Gene Therapy Laboratory

    Children’s Hospital of Philadelphia

    Dr. Yongping Wang is a pathologist in Philadelphia, PA and currently working as the Director of Cell and Gene Therapy Laboratory at Children's Hospital of Philadelphia. He received his medical degree from Geisel School of Medicine at Dartmouth and has been in practice for more than 15 years. He is one of 39 doctors at Children's Hospital of Philadelphia who specialize in Pathology. He has more than 20 publications and over 500 citings.

    Patrick Hanley, PhD

    ISCT NA Regional VP 2022-2024

    Chief & Director, Cellular Therapy Program, Associate Professor, Children’s National Hospital

    Dr. Hanley is the Chief and Director of the Cellular Therapy Program and an associate professor of pediatrics at Children’s National Hospital and the George Washington University, respectively. He oversees processing for standard of care stem cell transplantation as well as the development, manufacture, quality, and testing of novel cell and gene therapies. Over the past 16 years he has helped to translate more than 550 products on over 25 cell therapy protocols – ranging from mesenchymal stromal cells to cord blood virus-specific T cells and tumor-associated antigen specific T cells – into the clinic.

    Dr. Hanley was elected VP-North America of the International Society for Cell and Gene Therapy (ISCT) where he also serves on the board of directors, co-founded and served as the inaugural co-chair of the Early Stage Professionals committee which focuses on workforce development, and is the commissioning editor of the society’s journal, Cytotherapy. Representing ISCT, he serves on the Regenerative Medicine Forum of the National Academies where he co-leads the workforce working group. He also serves on the board of directors of the Foundation for the Accreditation of Cellular Therapy (FACT) and is a FACT representative at the Cell Therapy Liaison Meeting, serving as a thought leader in a forum with the FDA. Dr Hanley also serves as an advisor for a number of cell and gene therapy biotech companies. In his free time he enjoys tweeting with fellow scientists and Bills fans, playing soccer, cycling, cooking, and traveling.

    • Register
      • Member - Free!
      • Advanced Practice Professional Member - Free!
      • Complimentary Member - Free!
      • Industry Community - Free!
      • Industry Community Sub Account - Free!
      • Laboratory Member - Free!
      • Laboratory Technologist Sub Account - Free!
      • Laboratory Regular Member Sub Account - Free!
      • Laboratory Resident and Fellow Sub Account - Free!
      • Regular Member - Free!
      • Resident or Fellow Member - Free!
      • Student Member - Free!
      • Technologist Member - Free!
    • More Information
  • Contains 3 Component(s)

    Unlock the pathway to successful cell therapy approval in Australia with our ISCT exclusive webinar, "Getting Your Cell Therapy Product Approved: Some Dos and Don'ts." Hosted by experts from the Therapeutic Goods Administration (TGA), this event is your guide to navigating the intricacies of regulatory processes. Learn firsthand the crucial dos and don'ts that can make or break your cell therapy product's approval journey. Our distinguished speakers will delve into the nuanced requirements of the TGA, providing invaluable insights into crafting robust submissions, avoiding common pitfalls, and streamlining your approval process. Stay ahead of the curve by gaining a comprehensive understanding of Australia's regulatory landscape for cell therapies. Whether you're a seasoned professional or new to the regulatory realm, this webinar equips you with practical knowledge to optimize your strategy and enhance your chances of a successful approval. Seize this opportunity to engage directly with TGA officials, ask questions, and network with fellow industry professionals. Don't miss out! Register now for a transformative experience in advancing your cell therapy product through the regulatory maze Down Under.

    Presented by the ISCT ANZ Regional Executive Committee

    February 9, 2024

    Webinar Description:

    Unlock the pathway to successful cell therapy approval in Australia with our ISCT exclusive webinar, "Getting Your Cell Therapy Product Approved: Some Dos and Don'ts." Hosted by experts from the Therapeutic Goods Administration (TGA), this event is your guide to navigating the intricacies of regulatory processes.
    Learn firsthand the crucial dos and don'ts that can make or break your cell therapy product's approval journey. Our distinguished speakers will delve into the nuanced requirements of the TGA, providing invaluable insights into crafting robust submissions, avoiding common pitfalls, and streamlining your approval process.

    Stay ahead of the curve by gaining a comprehensive understanding of Australia's regulatory landscape for cell therapies. Whether you're a seasoned professional or new to the regulatory realm, this webinar equips you with practical knowledge to optimize your strategy and enhance your chances of a successful approval.
    Seize this opportunity to engage directly with TGA officials, ask questions, and network with fellow industry professionals. Don't miss out! Register now for a transformative experience in advancing your cell therapy product through the regulatory maze Down Under.

    Key Learning Objectives: 

    • Understand pathways and provisions for Cell Therapy products in Australia.
    • Learn what are the regulator expectations for compliance with relevant standards
    • Understand which manufacturing principles apply to cell therapies
    • Learn the dos and don’ts for cell therapy dossier development

    Zlatibor Velickovic, PhD (Moderator)

    ISCT ANZ Regional VP, A/Prof, Director

    CTTWA, Royal Perth Hospital, Australia

    Jessica Sue, MSc, MHSM (Moderator)

    ISCT ANZ Regional ESP Subcommittee Co-Chair, Quality Manager

    Sydney Cord Blood Bank

    Mat Adams, MD, PhD

    Senior Evaluator

    Biological Science Section, Scientific Evaluation Branch, Therapeutic Goods Administration, Australia

    Glenn Smith, MD, PhD

    Director

    Biological Science Section, Scientific Evaluation Branch, Therapeutic Goods Administration, Australia

    Tony Gill, MD

    Director

    Blood, Biologicals and Infectious Diseases Unit, Therapeutic Goods Administration, Australia

    • Register
      • Member - Free!
      • Advanced Practice Professional Member - Free!
      • Complimentary Member - Free!
      • Industry Community - Free!
      • Industry Community Sub Account - Free!
      • Laboratory Member - Free!
      • Laboratory Technologist Sub Account - Free!
      • Laboratory Regular Member Sub Account - Free!
      • Laboratory Resident and Fellow Sub Account - Free!
      • Regular Member - Free!
      • Resident or Fellow Member - Free!
      • Student Member - Free!
      • Technologist Member - Free!
    • More Information
  • Contains 6 Component(s)

    The Implementation of ISO Cell Counting Standards course is a partnership between ISCT and the Standards Coordinating Body (SCB). This course was developed by the Subject Matter Experts (SMEs), including NIST, FDA, and device manufacturers, who created the ISO 20391-1:2018 (Part 1) and ISO 20391-2:2019 (Part 2) Standards.

    The course comprised ten modules for approximately 10 hours of learning. Each module consists of a training video and a knowledge check (quiz). The last module of the course is the final examination consisting of 50 multiple-choice questions.  

    Learners have one attempt to complete and pass the final examination in order to obtain the certificate. 

    Any learner who failed the final examination may pay $250 to retake the course and examination once more. Please note that the re-examination fee must be paid within 30 days of the failed exam date. 

    • Register
      • Advanced Practice Professional Member - $1,295
      • Industry Community - $1,595
      • Industry Community Sub Account - $1,595
      • Laboratory Member - $1,295
      • Laboratory Technologist Sub Account - $1,295
      • Laboratory Regular Member Sub Account - $1,294.99
      • Laboratory Resident and Fellow Sub Account - $1,295
      • Regular Member - $1,595
      • Resident or Fellow Member - $1,295
      • Student Member - $1,294.99
      • Technologist Member - $1,295
    • More Information
  • Contains 5 Component(s)

    Join us for an insightful webinar on the "Emerging Techniques in Cell Replacement Therapy for Pancreatic Diseases." This session will dive deep into cutting-edge methodologies revolutionizing pancreatic disease treatments. Highlighted topics include state-of-the-art hPSCs protocols to derive beta-like cells—a promising avenue in regenerative medicine. Exploring innovative horizons, the webinar will also feature discussions on Decellularized Extracellular Matrix (ECM) used in the bioengineering of islets. Discover the significance of ECM in recreating a nurturing environment for islet development and functionality. Additionally, explore the frontiers of Islet Transplantation Sites, and their impact on successful transplantation outcomes. Don't miss this exclusive opportunity to expand your knowledge and understanding of these ground-breaking approaches in the field of pancreatic disease management.

    Presented by the ISCT Gastrointestinal Committee

    December 19, 2023

    Webinar Description:

    Join us for an insightful webinar on the "Emerging Techniques in Cell Replacement Therapy for Pancreatic Diseases." This session will dive deep into cutting-edge methodologies revolutionizing pancreatic disease treatments. Highlighted topics include state-of-the-art hPSCs protocols to derive beta-like cells—a promising avenue in regenerative medicine. Exploring innovative horizons, the webinar will also feature discussions on Decellularized Extracellular Matrix (ECM) used in the bioengineering of islets. Discover the significance of ECM in recreating a nurturing environment for islet development and functionality. Additionally, explore the frontiers of Islet Transplantation Sites, and their impact on successful transplantation outcomes. Don't miss this exclusive opportunity to expand your knowledge and understanding of these ground-breaking approaches in the field of pancreatic disease management.

    Key Learning Objectives: 

    The webinar will provide an overview and discussion of cutting-edge cells replacement therapy for diabetes.  In this 1 h webinar we will illustrate and discuss the following topics:

    - hPSCs protocols to derive beta like cells.
    - Decellularized ECM for islet bioengineering.
    - Islet transplantation sites.

    Vincenzo Cardinale, MD, PhD (Moderator)

    Associate Professor of Gastroenterology and Hepatology

    Sapienza University of Rome

    Adriana Migliorini, PhD

    Senior Post-Doctoral fellow

    McEwen Stem cell Institute

    Amish Asthana, PhD

    Assistant Professor

    Wake Forest School of Medicine

    Hongjun Wang, PhD

    Professor

    Medical University of South Carolina (MUSC)

    • Register
      • Member - Free!
      • Advanced Practice Professional Member - Free!
      • Complimentary Member - Free!
      • Industry Community - Free!
      • Industry Community Sub Account - Free!
      • Laboratory Member - Free!
      • Laboratory Technologist Sub Account - Free!
      • Laboratory Regular Member Sub Account - Free!
      • Laboratory Resident and Fellow Sub Account - Free!
      • Regular Member - Free!
      • Resident or Fellow Member - Free!
      • Student Member - Free!
      • Technologist Member - Free!
    • More Information
  • Contains 54 Component(s)

    This program is designed for the existing biomanufacturing workforce, entry level personnel, graduate and advanced undergraduate students, as well as those entering from another field, to develop the fundamental skillset and knowledge unique to CGT manufacturing.

    Developed by field experts from academia, regulatory, clinical, and commercial domains, this program provides a vital training opportunity to develop the fundamental skillset and knowledge unique to CGT manufacturing and to upskill key personnel for roles within companies and clinical manufacturing centres across the Cell & Gene Therapy (CGT) sector. 

    Each module includes a series of asynchronous lectures comprised of Theory and Application components as well as a LIVE Expert Panel Discussion and Q&A Session. Participants will receive a certificate of completion upon completion of module assessments.

    • Register
      • Non-member - $1,895
      • Advanced Practice Professional Member - $795
      • Complimentary Member - $795
      • Emeritus Member - $795
      • Industry Community - $1,495
      • Industry Community Sub Account - $1,495
      • Laboratory Member - $795
      • Laboratory Technologist Sub Account - $795
      • Laboratory Regular Member Sub Account - $795
      • Laboratory Resident and Fellow Sub Account - $250
      • Non-member Advanced Practice Professional - $1,295
      • Non-member Regular - $1,895
      • Non-member Resident or Fellow - $1,895
      • Non-member Technologist - $1,895
      • Regular Member - $1,495
      • Resident or Fellow Member - $250
      • Student Member - $250
      • Technologist Member - $795
    • More Information
  • Contains 12 Component(s)

    A concise overview for professionals looking to learn the essentials of cell product development, qualification, validation, stability, and regulatory submissions.

    Essentials of Cell Therapy Product Manufacturing, Qualification and Validation

    Designed for experienced CGT staff and lab managers to learn topics related to process validation and manufacturing.

    • Developing a CAR-T Program
      • Does terminology matter?
      • Practical FDA recommendations
      • Test method qualification requirements
      • Has the goalpost been moved?
      • Starting materials for IND-type products (tissues, cell lines) and manufacturing
    • Developing a Validated Assay That Will Please the FDA
      • Assay qualification or validation
      • Potency assay
      • Stability testing
    • Role of Manufacturing in Regulatory Submissions
      • CMC preparation and expectations
      • Considerations in filing an IND, FDA pathways, and designations
      • FDA interactions
    • Cryopreservation and Stability
      • Cryopreservation
      • Thawing methods
      • Stability studies
    • Register
      • Advanced Practice Professional Member - $100
      • Emeritus Member - $125
      • Industry Community - $200
      • Industry Community Sub Account - $200
      • Laboratory Member - $100
      • Laboratory Technologist Sub Account - $100
      • Laboratory Regular Member Sub Account - $100
      • Laboratory Resident and Fellow Sub Account - $100
      • Regular Member - $200
      • Resident or Fellow Member - $85
      • Student Member - $85
      • Technologist Member - $100
    • More Information
  • Contains 12 Component(s)

    Developed for professionals new to the cell and gene therapy field to learn the fundamentals of cell collection, processing, storage, quality control, distribution, and regulatory requirements.

    Cell Product Handling & Regulatory 101

    Designed for any beginners to the CGT field to learn the basics of manufacturing a cell therapy treatment.

    • Collections
      • Cell sources and how they are collected (apheresis, bone marrow, cord blood)
      • Comparison of the different cell sources (apheresis vs bone marrow vs cord blood)
      • Types of donors (haploidentical, matched related, matched unrelated)
      • Donor suitability and eligibility
    • Processing and QC
      • Basic processing techniques
      • Manual vs automated systems
      • Fundamentals & advances in processing and manufacturing – the example of RBC reduction
    • Quality Assurance/Regulatory
      • Operational GTPs
      • Nonconformities & deviations: communication & roles
      • Product release
    • Product Storage, Distribution & Logistics
      • Scheduling, orders & communication
      • Shipping vs transportation
      • Equipment associated with storage and distribution
      • Thawing, tracking
    • Register
      • Advanced Practice Professional Member - $100
      • Emeritus Member - $125
      • Industry Community - $200
      • Industry Community Sub Account - $200
      • Laboratory Member - $100
      • Laboratory Technologist Sub Account - $100
      • Laboratory Regular Member Sub Account - $100
      • Laboratory Resident and Fellow Sub Account - $100
      • Regular Member - $200
      • Resident or Fellow Member - $85
      • Student Member - $85
      • Technologist Member - $100
    • More Information
  • Contains 3 Component(s)

    AusBiotech and Medicines Australia have partnered to co-lead a new Cell and Gene Catalyst initiative. This national joint venture is a collaborative effort between the two peak industry bodies. The Catalyst aims to accelerate the development and commercialisation of cell and gene therapies in Australia and strengthen Australian capabilities across the entire value chain.

    Presented by the ISCT ANZ Regional Executive Committee

    November 23, 2023
    Webinar Description:

    AusBiotech and Medicines Australia have partnered to co-lead a new Cell and Gene Catalyst initiative. This national joint venture is a collaborative effort between the two peak industry bodies. The Catalyst aims to accelerate the development and commercialisation of cell and gene therapies in Australia and strengthen Australian capabilities across the entire value chain. 


    In this webinar, Dr Marguerite Evans-Galea AM will outline Catalyst’s role in establishing an end-to-end value chain for discovering, developing, manufacturing and distributing world-class cell and gene therapies while promoting job creation and commercialising research in Australia. Dr Evans-Galea will provide an overview of the National Cell and Gene Manufacturing Blueprint recently published by Ausbiotech and discuss approaches to expand manufacturing capabilities and capacity in Australia.

    Key Learning Objectives: 
    • Attract, build, and retain world-class talent to support skillset and workforce requirements
    • Foster collaboration and knowledge sharing across the industry to accelerate the pace of innovation
    • Create a clear regulatory and market access pathway that is aligned with global markets, ensuring that new therapies can reach patients
    • Build Australian capability from research and development to manufacturing, clinical trials and successful commercialization.

    Zlatibor Velickovic, PhD (Moderator)

    ISCT ANZ Regional VP, 2022-2024

    Royal Perth Hospital

    Emily Blyth, FRACP, FRCPA, PhD (Moderator)

    ISCT ANZ Regional VP-Elect, 2022-2024

    Westmead Hospital

    Marguerite Evans-Galea AM, PhD

    Director

    Cell and Gene Catalyst, AusBiotech

    • Register
      • Member - Free!
      • Advanced Practice Professional Member - Free!
      • Complimentary Member - Free!
      • Industry Community - Free!
      • Industry Community Sub Account - Free!
      • Laboratory Member - Free!
      • Laboratory Technologist Sub Account - Free!
      • Laboratory Regular Member Sub Account - Free!
      • Laboratory Resident and Fellow Sub Account - Free!
      • Regular Member - Free!
      • Resident or Fellow Member - Free!
      • Student Member - Free!
      • Technologist Member - Free!
    • More Information
  • Contains 1 Component(s)

    Join our webinar, "CAR-T: Historical Perspectives, Manufacturing, and Clinical Applications," to uncover the revolutionary world of CAR-T cell therapy. Discover the historical journey and core principles that led to this cutting-edge treatment, and explore the intricacies of its manufacturing process. Delve into its diverse clinical applications, showcasing its potential in transforming patient

    Presented by the ISCT SCA Regional Executive Committee

    October 19, 2023

    Webinar Description:

    Join our webinar, "CAR-T: Historical Perspectives, Manufacturing, and Clinical Applications," to uncover the revolutionary world of CAR-T cell therapy. Discover the historical journey and core principles that led to this cutting-edge treatment, and explore the intricacies of its manufacturing process. Delve into its diverse clinical applications, showcasing its potential in transforming patient 

    Key Learning Objectives: 

    This webinar will delve into the revolutionary field of CAR-T cell therapy, exploring its impact in crucial areas such as history and principles, manufacturing processes, and its diverse range of clinical applications.

    CAR-T cell therapy has emerged as a groundbreaking immunotherapy, holding immense promise in the treatment of various diseases, particularly hematologic malignancies. Understanding the core principles and historical context of CAR-T therapy is vital in comprehending its evolution and success.

    1. History and Principles:
    By delving into the historical perspectives of CAR-T cell therapy, we aim to provide participants with a comprehensive understanding of its development and evolution. From the early concepts to the groundbreaking achievements, this segment will showcase the journey of CAR-T therapy and its transformation into a cutting-edge treatment modality.

    2. Manufacturing:
    The manufacturing process plays a pivotal role in CAR-T therapy, influencing its efficacy and safety. We will highlight the complexities and innovations in CAR-T cell production, emphasizing the importance of quality control and standardization in ensuring the therapeutic success of CAR-T treatments.

    3. Clinical Applications:
    The clinical applications of CAR-T therapy have expanded rapidly, encompassing a wide range of diseases and patient populations. In this segment, we will explore the latest clinical advancements and successes of CAR-T therapy, discussing its impact on patient outcomes and its potential to revolutionize medical practices.

    The importance of this webinar lies in the transformative potential of CAR-T cell therapy and its ability to bring about positive changes in patients' lives. This is exemplified by research studies, which explored the influence of social determinants of health on CAR-T therapy outcomes for young patients with relapsed/refractory B-acute lymphoblastic leukemia (B-ALL)/lymphoma.

    This reinforces the need for equitable and accessible healthcare systems, so that vulnerable populations can benefit from the advancements in CAR-T therapy as well in South and central America.

    • Register
      • Member - Free!
      • Advanced Practice Professional Member - Free!
      • Complimentary Member - Free!
      • Industry Community - Free!
      • Industry Community Sub Account - Free!
      • Laboratory Member - Free!
      • Laboratory Technologist Sub Account - Free!
      • Laboratory Regular Member Sub Account - Free!
      • Laboratory Resident and Fellow Sub Account - Free!
      • Regular Member - Free!
      • Resident or Fellow Member - Free!
      • Student Member - Free!
      • Technologist Member - Free!
    • More Information
  • Contains 1 Component(s)

    Thailand is strategically poised to establish itself as a prominent medical hub in the Asian region, boasting an exceptional medical infrastructure, skilled healthcare specialists, and a multitude of internationally accredited medical facilities. Consequently, Thailand's medical services have garnered global recognition.

    Presented by the ISCT Asia Regional Executive Committee

    September 28, 2023

    Webinar Description:

    Thailand is strategically poised to establish itself as a prominent medical hub in the Asian region, boasting an exceptional medical infrastructure, skilled healthcare specialists, and a multitude of internationally accredited medical facilities. Consequently, Thailand's medical services have garnered global recognition.


    Advanced Therapy Medicinal Products (ATMPs) are promising medical products that will break through the constraints of current standard therapies.  The burgeoning ATMP manufacturing sector in Thailand is facing considerable demand from advanced therapy service sites.  Additionally, technology and manufacturing standards are being established based on FDA guidelines to support sustainable development, and the Thai government has progressive policies and incentives to support this growing sector.  

    Key Learning Objectives: 

    To provide information about the promotion and development of the ATMP industry in Thailand including:

    • Market authorization
    • Product development (specifically clinical phase)
    • Government support policy for ATMP manufacturing investment 
    • Example from the Thai private sector - successful regulatory approval process
    • Register
      • Member - Free!
      • Advanced Practice Professional Member - Free!
      • Complimentary Member - Free!
      • Industry Community - Free!
      • Industry Community Sub Account - Free!
      • Laboratory Member - Free!
      • Laboratory Technologist Sub Account - Free!
      • Laboratory Regular Member Sub Account - Free!
      • Laboratory Resident and Fellow Sub Account - Free!
      • Regular Member - Free!
      • Resident or Fellow Member - Free!
      • Student Member - Free!
      • Technologist Member - Free!
    • More Information